-
Correlation of expression of CD44 isoforms and E-cadherin with differentiation in human urothelial cell lines and transitional cell carcinoma.
Cancer Lett. 1995 Feb 10;89(1):81-7
PMID: 7533658
-
A novel ligand for CD44 is serglycin, a hematopoietic cell lineage-specific proteoglycan. Possible involvement in lymphoid cell adherence and activation.
J Biol Chem. 1995 Mar 31;270(13):7437-44
PMID: 7535771
-
Regulation of CD44-protein 4.1 interaction by Ca2+ and calmodulin. Implications for modulation of CD44-ankyrin interaction.
J Biol Chem. 1997 Nov 28;272(48):30322-8
PMID: 9374519
-
Induction of apoptosis of metastatic mammary carcinoma cells in vivo by disruption of tumor cell surface CD44 function.
J Exp Med. 1997 Dec 15;186(12):1985-96
PMID: 9396767
-
Identification of CD44 residues important for hyaluronan binding and delineation of the binding site.
J Biol Chem. 1998 Jan 2;273(1):338-43
PMID: 9417085
-
Proinflammatory stimuli regulate endothelial hyaluronan expression and CD44/HA-dependent primary adhesion.
J Clin Invest. 1998 Jan 1;101(1):97-108
PMID: 9421471
-
Ezrin/radixin/moesin (ERM) proteins bind to a positively charged amino acid cluster in the juxta-membrane cytoplasmic domain of CD44, CD43, and ICAM-2.
J Cell Biol. 1998 Feb 23;140(4):885-95
PMID: 9472040
-
Over-expression of human CD44s in murine 3T3 cells: selection against during primary tumorigenesis and selection for during micrometastasis.
Clin Exp Metastasis. 1998 Jan;16(1):83-93
PMID: 9502080
-
Blockade of metastasis formation by CD44-receptor globulin.
Int J Cancer. 1998 Mar 16;75(6):919-24
PMID: 9506538
-
The ankyrin-binding domain of CD44s is involved in regulating hyaluronic acid-mediated functions and prostate tumor cell transformation.
Cell Motil Cytoskeleton. 1998;39(3):209-22
PMID: 9519902
-
Co-expression of osteopontin and CD44v9 in gastric cancer.
Int J Cancer. 1998 Apr 17;79(2):127-32
PMID: 9583725
-
Coupling of signal transduction to alternative pre-mRNA splicing by a composite splice regulator.
EMBO J. 1998 May 15;17(10):2904-13
PMID: 9582284
-
CD44v(3,8-10) is involved in cytoskeleton-mediated tumor cell migration and matrix metalloproteinase (MMP-9) association in metastatic breast cancer cells.
J Cell Physiol. 1998 Jul;176(1):206-15
PMID: 9618160
-
Identification and functional analysis of the ezrin-binding site in the hyaluronan receptor, CD44.
Curr Biol. 1998 Jun 4;8(12):705-8
PMID: 9637922
-
Inhibition of tumor growth in vivo by hyaluronan oligomers.
Int J Cancer. 1998 Jul 29;77(3):396-401
PMID: 9663602
-
CD44 variant exon v5 encodes a tyrosine that is sulphated.
Eur J Biochem. 1998 Jul 1;255(1):74-80
PMID: 9692903
-
Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment.
Cancer Res. 1998 Aug 15;58(16):3719-26
PMID: 9721884
-
Functional activation of lymphocyte CD44 in peripheral blood is a marker of autoimmune disease activity.
J Clin Invest. 1998 Sep 15;102(6):1173-82
PMID: 9739051
-
Engagement of variant CD44 confers resistance to anti-integrin antibody-mediated apoptosis in a colon carcinoma cell line.
Cell Adhes Commun. 1998 Jun;6(1):21-38
PMID: 9759519
-
Expression of the NG2 proteoglycan enhances the growth and metastatic properties of melanoma cells.
J Cell Physiol. 1998 Nov;177(2):299-312
PMID: 9766527
-
CD44 isoform-cytoskeleton interaction in oncogenic signaling and tumor progression.
Front Biosci. 1998 Jul 1;3:d637-49
PMID: 9634539
-
Clinical implications of anomalous CD44 gene expression in neoplasia.
Front Biosci. 1998 Jul 1;3:e89-109
PMID: 9634541
-
The role of hyaluronic acid in intercellular adhesion of cultured mouse cells.
Exp Cell Res. 1978 Nov;117(1):155-64
PMID: 720401
-
The gene, MIC4, which controls expression of the antigen defined by monoclonal antibody F10.44.2, is on human chromosome 11.
Eur J Immunol. 1982 Aug;12(8):659-63
PMID: 7140811
-
Aggregation of macrophages and fibroblasts is inhibited by a monoclonal antibody to the hyaluronate receptor.
Exp Cell Res. 1988 Oct;178(2):224-32
PMID: 2458949
-
A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family.
Cell. 1989 Mar 24;56(6):1057-62
PMID: 2466575
-
The hyaluronate receptor is preferentially expressed on proliferating epithelial cells.
J Cell Biol. 1989 Apr;108(4):1557-65
PMID: 2466850
-
Identification of mRNA that encodes an alternative form of H-CAM(CD44) in lymphoid and nonlymphoid tissues.
Immunogenetics. 1990;32(6):389-97
PMID: 2272659
-
The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells.
EMBO J. 1991 Feb;10(2):343-8
PMID: 1991450
-
A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells.
Cell. 1991 Apr 5;65(1):13-24
PMID: 1707342
-
Acylation of the lymphoma transmembrane glycoprotein, GP85, may be required for GP85-ankyrin interaction.
J Biol Chem. 1991 Jun 25;266(18):11761-5
PMID: 1828806
-
Molecular cloning of CD44R1 and CD44R2, two novel isoforms of the human CD44 lymphocyte "homing" receptor expressed by hemopoietic cells.
J Exp Med. 1991 Jul 1;174(1):1-5
PMID: 2056274
-
CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumor cell lines.
Cancer Res. 1991 Oct 1;51(19):5292-7
PMID: 1717145
-
Distinct effects of two CD44 isoforms on tumor growth in vivo.
J Exp Med. 1991 Oct 1;174(4):859-66
PMID: 1919439
-
Isolation and characterization of human melanoma cell variants expressing high and low levels of CD44.
Cancer Res. 1991 Dec 15;51(24):6660-7
PMID: 1742741
-
A cell surface chondroitin sulfate proteoglycan, immunologically related to CD44, is involved in type I collagen-mediated melanoma cell motility and invasion.
J Cell Biol. 1992 Jan;116(2):521-31
PMID: 1730766
-
Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin.
J Cell Biol. 1992 Feb;116(3):817-25
PMID: 1730778
-
Participation in normal immune responses of a metastasis-inducing splice variant of CD44.
Science. 1992 Jul 31;257(5070):682-5
PMID: 1496383
-
CD44H regulates tumor cell migration on hyaluronate-coated substrate.
J Cell Biol. 1992 Aug;118(4):971-7
PMID: 1380003
-
Inhibition of tumor growth in vivo with a soluble CD44-immunoglobulin fusion protein.
J Exp Med. 1992 Aug 1;176(2):623-7
PMID: 1500863
-
Variant cell lines selected for alterations in the function of the hyaluronan receptor CD44 show differences in glycosylation.
J Exp Med. 1995 Aug 1;182(2):431-7
PMID: 7543138
-
Patterns of splice variant CD44 expression by normal human urothelium in situ and in vitro and by bladder-carcinoma cell lines.
Int J Cancer. 1995 Aug 9;62(4):449-56
PMID: 7543458
-
CD44 (Pgp-1) inhibits CD3 and dexamethasone-induced apoptosis.
Blood. 1995 Oct 1;86(7):2672-8
PMID: 7545465
-
Abnormal retention of intron 9 in CD44 gene transcripts in human gastrointestinal tumors.
Cancer Res. 1995 Oct 1;55(19):4273-7
PMID: 7545538
-
N-terminal and central regions of the human CD44 extracellular domain participate in cell surface hyaluronan binding.
J Immunol. 1995 Oct 15;155(8):3938-45
PMID: 7561101
-
Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon.
J Cell Biol. 1995 Feb;128(4):673-85
PMID: 7532175
-
Chondroitin sulphate composition and structure in alternatively spliced CD44 fusion proteins.
Biochem J. 1997 Oct 15;327 ( Pt 2):499-506
PMID: 9359422
-
Widespread expression of chondroitin sulfate-type serglycins with CD44 binding ability in hematopoietic cells.
J Biol Chem. 1997 Oct 17;272(42):26714-9
PMID: 9334256
-
Interaction between the adhesion receptor, CD44, and the oncogene product, p185HER2, promotes human ovarian tumor cell activation.
J Biol Chem. 1997 Oct 31;272(44):27913-8
PMID: 9346940
-
Requirement for CD44 in activated T cell extravasation into an inflammatory site.
Science. 1997 Oct 24;278(5338):672-5
PMID: 9381175
-
Lymph node (but not spleen) invasion by murine lymphoma is both CD44- and hyaluronate-dependent.
J Immunol. 1995 May 15;154(10):5345-55
PMID: 7537306
-
CD44 variant isoforms in non-Hodgkin's lymphoma: a new independent prognostic factor.
Blood. 1995 May 15;85(10):2885-99
PMID: 7537983
-
Involvement of CD44 variant isoforms in hyaluronate adhesion by human activated T cells.
Eur J Immunol. 1995 Oct;25(10):2932-9
PMID: 7589094
-
To metastasize or not? Selection of CD44 splice sites.
Nat Med. 1995 Jul;1(7):635-7
PMID: 7585142
-
Differential expression of CD44 splice variants in human pancreatic adenocarcinoma and in normal pancreas.
Cancer Res. 1995 Dec 1;55(23):5499-503
PMID: 7585621
-
Unusual retention of introns in CD44 gene transcripts in bladder cancer provides new diagnostic and clinical oncological opportunities.
J Pathol. 1995 Sep;177(1):11-20
PMID: 7472774
-
Regulation of CD44 binding to hyaluronan by glycosylation of variably spliced exons.
J Cell Biol. 1995 Dec;131(6 Pt 1):1623-33
PMID: 8522617
-
Oncogene-dependent expression of CD44 in Balb/c 3T3 derivatives: correlation with metastatic competence.
Clin Exp Metastasis. 1996 Jan;14(1):73-82
PMID: 8521619
-
Targeted disruption of CD44 in MDAY-D2 lymphosarcoma cells has no effect on subcutaneous growth or metastatic capacity.
J Cell Biol. 1995 Dec;131(6 Pt 2):1849-55
PMID: 8557751
-
Receptor-ligand interaction between CD44 and osteopontin (Eta-1).
Science. 1996 Jan 26;271(5248):509-12
PMID: 8560266
-
Evidence of involvement of CD44 in endothelial cell proliferation, migration and angiogenesis in vitro.
Int J Cancer. 1996 May 29;66(5):664-8
PMID: 8647630
-
A cysteine residue located in the transmembrane domain of CD44 is important in binding of CD44 to hyaluronic acid.
J Exp Med. 1996 May 1;183(5):1987-94
PMID: 8642309
-
Hyaluronate-independent metastatic behavior of CD44 variant-expressing pancreatic carcinoma cells.
Cancer Res. 1996 Jul 1;56(13):3134-41
PMID: 8674073
-
The CD44 proteins in embryonic development and in cancer.
Curr Top Microbiol Immunol. 1996;213 ( Pt 1):249-69
PMID: 8814991
-
Does soluble CD44 reflect the clinical behavior of human cancer?
Curr Top Microbiol Immunol. 1996;213 ( Pt 3):155-66
PMID: 8815003
-
A splice variant of CD44 expressed in the rat apical ectodermal ridge contributes to limb outgrowth.
Ann N Y Acad Sci. 1996 Jun 8;785:345-9
PMID: 8702177
-
Cellular distribution of CD44 gene transcripts in colorectal carcinomas and in normal colonic mucosa.
J Clin Pathol. 1996 Jun;49(6):482-8
PMID: 8763263
-
Accelerated immune response in transgenic mice expressing rat CD44v4-v7 on T cells.
J Immunol. 1996 Mar 15;156(6):2085-94
PMID: 8690896
-
Trans-acting factors regulate the expression of CD44 splice variants.
EMBO J. 1996 Aug 1;15(15):4030-9
PMID: 8670907
-
Role of CD44 in the reaction of vascular smooth muscle cells to arterial wall injury.
J Clin Invest. 1996 Aug 1;98(3):877
PMID: 8698880
-
Progressive loss of CD44 gene expression in invasive bladder cancer.
Am J Pathol. 1996 Sep;149(3):873-82
PMID: 8780391
-
Solution structure of the link module: a hyaluronan-binding domain involved in extracellular matrix stability and cell migration.
Cell. 1996 Sep 6;86(5):767-75
PMID: 8797823
-
CD44/chondroitin sulfate proteoglycan and alpha 2 beta 1 integrin mediate human melanoma cell migration on type IV collagen and invasion of basement membranes.
Mol Biol Cell. 1996 Mar;7(3):383-96
PMID: 8868467
-
CD44 protein levels and its biological activity are regulated in Balb/c 3T3 fibroblasts by serum factors and by transformation with the ras but not with the sis oncogene.
J Cell Physiol. 1996 Nov;169(2):341-9
PMID: 8908201
-
Analysis of anomalous CD44 gene expression in human breast, bladder, and colon cancer and correlation of observed mRNA and protein isoforms.
Am J Pathol. 1996 Nov;149(5):1519-30
PMID: 8909242
-
Induction of fibroblast apoptosis by anti-CD44 antibody: implications for the treatment of fibroproliferative lung disease.
Am J Pathol. 1996 Nov;149(5):1639-50
PMID: 8909253
-
Regulated clustering of variant CD44 proteins increases their hyaluronate binding capacity.
J Cell Biol. 1996 Nov;135(4):1139-50
PMID: 8922392
-
Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44.
J Clin Invest. 1996 Nov 15;98(10):2403-13
PMID: 8941660
-
Increased serum levels of soluble CD44 standard, but not of variant isoforms v5 and v6, in B cell chronic lymphocytic leukemia.
Leukemia. 1997 Jan;11(1):134-41
PMID: 9001429
-
Interaction between CD44 and osteopontin as a potential basis for metastasis formation.
Proc Assoc Am Physicians. 1997 Jan;109(1):1-9
PMID: 9010911
-
CD44 expression in human breast cancer cell lines is related to oestrogen receptor (ER) status and confluency in vitro.
Biochem Soc Trans. 1997 May;25(2):356S
PMID: 9191401
-
Rapid analysis of distinctive CD44 RNA splicing preferences that characterize colonic tumors.
Cancer Res. 1997 Aug 1;57(15):3140-4
PMID: 9242440
-
CD44 activation and associated primary adhesion is inducible via T cell receptor stimulation.
J Immunol. 1997 Sep 15;159(6):2549-53
PMID: 9300670
-
Multiple intron retention occurs in tumor cell CD44 mRNA processing.
Am J Pathol. 1998 Oct;153(4):1221-8
PMID: 9777953
-
Novel CD44 messenger RNA isoforms in human thyroid and breast tissues feature unusual sequence rearrangements.
Clin Cancer Res. 1996 Aug;2(8):1251-4
PMID: 9816294
-
CD44 variant isoforms are essential for the function of epidermal Langerhans cells and dendritic cells.
Cell Adhes Commun. 1998;6(2-3):157-60
PMID: 9823467
-
No evidence for cancer-related CD44 splice variants in primary and metastatic colorectal cancer.
Eur J Cancer. 1998 Jun;34(7):1099-1104
PMID: 9849461
-
Disorderly CD44 gene expression in human cancer cells can be modulated by growth conditions.
J Pathol. 1998 Sep;186(1):17-23
PMID: 9875135
-
Identification of two regions in the cytoplasmic domain of CD44 through which PMA, calcium, and foskolin differentially regulate the binding of CD44 to hyaluronic acid.
Cell Immunol. 1998 Dec 15;190(2):132-40
PMID: 9878114
-
Heregulin and agonistic anti-p185(c-erbB2) antibodies inhibit proliferation but increase invasiveness of breast cancer cells that overexpress p185(c-erbB2): increased invasiveness may contribute to poor prognosis.
Clin Cancer Res. 1997 Sep;3(9):1629-34
PMID: 9815853
-
Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons.
Proc Natl Acad Sci U S A. 1992 Dec 15;89(24):12160-4
PMID: 1465456
-
Prevention of tumor metastasis formation by anti-variant CD44.
J Exp Med. 1993 Feb 1;177(2):443-55
PMID: 8426113
-
The two major CD44 proteins expressed on a metastatic rat tumor cell line are derived from different splice variants: each one individually suffices to confer metastatic behavior.
Cancer Res. 1993 Mar 15;53(6):1262-8
PMID: 8443806
-
Splicing choice from ten variant exons establishes CD44 variability.
Nucleic Acids Res. 1993 Mar 11;21(5):1225-9
PMID: 8464707
-
The identification of a new alternative exon with highly restricted tissue expression in transcripts encoding the mouse Pgp-1 (CD44) homing receptor. Comparison of all 10 variable exons between mouse, human, and rat.
J Biol Chem. 1993 Jun 15;268(17):12235-8
PMID: 8509359
-
Identification of hyaluronic acid binding sites in the extracellular domain of CD44.
J Cell Biol. 1993 Jul;122(1):257-64
PMID: 8314845
-
Antibody-induced activation of the hyaluronan receptor function of CD44 requires multivalent binding by antibody.
Eur J Immunol. 1993 Aug;23(8):1902-9
PMID: 7688309
-
CD44 and its interaction with extracellular matrix.
Adv Immunol. 1993;54:271-335
PMID: 8379464
-
Alternatively spliced CD44 transcripts in diffuse large-cell lymphomas: characterization and comparison with normal activated B cells and epithelial malignancies.
Blood. 1993 Dec 15;82(12):3539-47
PMID: 7505117
-
A PCR-based method for the analysis of human CD44 splice products.
PCR Methods Appl. 1993 Oct;3(2):100-6
PMID: 7505677
-
Expression and modulation of CD44 variant isoforms in humans.
J Cell Biol. 1994 Jan;124(1-2):71-82
PMID: 7507492
-
Identification of a common hyaluronan binding motif in the hyaluronan binding proteins RHAMM, CD44 and link protein.
EMBO J. 1994 Jan 15;13(2):286-96
PMID: 7508860
-
Non-invasive detection of malignancy by identification of unusual CD44 gene activity in exfoliated cancer cells.
BMJ. 1994 Mar 5;308(6929):619-24
PMID: 8148709
-
Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development.
J Exp Med. 1994 Jul 1;180(1):53-66
PMID: 7516417
-
A novel ligand for CD44 is sulfated proteoglycan.
Int Immunol. 1994 Apr;6(4):655-60
PMID: 7517179
-
ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons.
J Cell Biol. 1994 Jul;126(2):391-401
PMID: 7518464
-
Ankyrin-binding domain of CD44(GP85) is required for the expression of hyaluronic acid-mediated adhesion function.
J Cell Biol. 1994 Aug;126(4):1099-109
PMID: 7519619
-
CD44 variant isoforms are preferentially expressed in basal epithelial of non-malignant human fetal and adult tissues.
Histochemistry. 1994 Feb;101(2):79-89
PMID: 7520892
-
Characterization of soluble CD44 in the circulation of mice. Levels are affected by immune activity and tumor growth.
J Immunol. 1994 Oct 15;153(8):3440-9
PMID: 7523494
-
New CD44 splice variants associated with human breast cancers.
J Cell Physiol. 1995 Jan;162(1):127-33
PMID: 7529235
-
Expression of CD44 splice variants during lymphocyte activation and tumor progression.
Cell Adhes Commun. 1994 Jul;2(3):195-200
PMID: 7530151
-
Significance of CD44 gene products for cancer diagnosis and disease evaluation.
Lancet. 1992 Oct 31;340(8827):1053-8
PMID: 1357452
-
CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor.
J Cell Biol. 1995 Feb;128(4):687-98
PMID: 7532176
-
Role of CD44 cytoplasmic domain in hyaluronan binding.
Eur J Immunol. 1995 Feb;25(2):495-501
PMID: 7533087